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In support ofthe diabetes research of Paul E. Lacy, M.D., Ph.D., and David W. Scharp,
M.D., the Barnes Hospital Islet Processing Lab was prepared for a March opening. The
process, developed at the medical school, produces purified, vital islet cells from pancreata
acquired from organ donors. The lab's technical supervisor, Dan Fraga, is shown at one of five
isolators in which the organs are washed, dissected, broken down into cell aggregates, purified
and cryofrozen for banking. The preparations are then pooled for transplantation to diabetic
patients who have had kidney transplants or are taking immunosuppressive drugs.
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On The Cover:
In pursuit of effective gene
therapy , medical sc hool research
ers install genes in many types of
cells. In the experiments recorded
on the cover, David Leib , Ph.D.,
and Jay Pepose, M.D., Ph.D.,
tested a particular gene promoter
(the DNA sequence that instlllcts a
gene to express the protein for
which it encodes) to demonstrate
its effecti ve ness in neurons. They
were especially interes ted in
res ults shown in the third ex
amples from the left in the bottom
two rows. The ce lls in those
samples are retinal cells that
clearly contain the active gene
promoter, as shown by the blu e
stain. Story on page 12.
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Newsbriefs
he votes have been
cast and certi fi ed by
the university' s
Board of Tru stees, and the
School of Medicin e will of
fer a clinician track for doc 
tors who spend more time
teaching and caring for pa
tients than doing research.
In a vote open to th e en
tire faculty on November 6,
amendments to the tenure
policy to make a cJinician
track possible were appro ved
by a four-to-one margin, ac
cording to John N . Drobak,
1.0. , professor of law and
chairman of the Senate
Council , an elected body that
represents faculty interests in
university policy deci sions.
"This is a major change in
tenure policy resulting from
a year-and-a-half of dialogue
between the medical school
administration and faculty ,"
Drobak says. "There was full
and open discussion , and the
end result is that a new
career path

T
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wa y for physicians is being
established that wi II better
serve the needs of th e School
of Medicine. "
In awarding tenure , th e
university always has
stressed the importance of
research, explains James P.
Crane, M.D., associate vice
chancellor and associate
dean for clinical affairs at
the School of Medicine.
While excellence in research
will remain a critical part of
the academic mi ssion, he
points out that the demand s
and complexity of medicine
make it essential that some
individuals devote a major
portion of their time to pa
tient care and teaching.
The clinician track, Crane
says, rewards physicians for
excellence in patient care
and teaching. It also should
ass ure a stable patient load
to provide adequate learning
opportunities for medical
students and
house sta ff. In

according to Crane, in
crea sed clinician activity
will benefit research by
bringing in more pati ents to
participate in studies. And
clinical revenues, he adds,
will help support teaching
and research activities in
both the clinical and pre
clinical departments.
Professorial titles will be
the same for faculty on ei
ther the investigator or clini
ci an track .
" In the past, we have lost
some excellent clinicians and
teachers because we could
not promote them," Crane
says . "I believe the comple
mentary nature of the clini
cian and investigator
pathways should enhance the
ability of our faculty to excel
in all aspects of our aca
demic mission."
The School of Medicine
will join good company by
offering the clinician track .
Of the nation' s 126 medical
school s, 1 12 offer tenure
a nd , of those, 80 also have a
clinicia n track.
Crane and Drobak both
applaud Samuel A. Wells,
Jr., M.D., professor and head
of surgery, who chaired the
clinical pathw ay stee ring
committee, and William A.
Peck, M.D ., executiv e vice
chancellor for medical
a ffairs and dean of
the School of
Medicine, for their
initiati ve to secure
the future for
clinical
facuity . •
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avid 1. States, M.D.,
Ph.D., has been
named director of
the Institute for Biomedical
Computing at the School of
Medicine .

David J. States, M.D., Ph.D.
Formerly a senior staff
fellow at the National Li
brary of Medicine's Nationa l
Center for Biotechnology
Information (NCBl) , States
was responsible for the con
struction and analysis of mo
lecular sequence databases .
In conjunction with hi s
position at the medical
school , States also directs
the program in biomedical
engineering in the School of
Engineering and Applied
Science on the Hilltop cam
pus. States will oversee ex
pansion of the network
communication systems that
will enable more researchers
to have access to electronic
data information. "My goal

is that network communica
tions use will become more
widespread and routine at
Washington University, an
institution which already ha s
ex pertise in the area of elec
tronic communications,"
says States. "E lectronic com
munication s are an impol1ant
aspect of the researc h envi
ronment, and we need to see
that all of the university has
access."
In addition, States will be
principal investigator on the
analysis component of the C
e/egans Genome Sequencing
Center. His primary research
intere st is large-scal e mo
lecular seq uencing and the
analysis of genome sequence
data . •

Afftliaiioll
Renp"lvcfl
ewish Hospital and
Washington Universi ty
have renewed their af
filiation with th e ap proval of
a new IS-yea r agreement by
the Jewi sh Hospital Board of
Directors. The Washington
University Board of Tru stees
had already approved th e
agree ment in principle and
authorized officers of the
School of Medicine to com
plete the negotiations.
The new contract aligns
responsibilities according to
the missions of both institu
tions and positions them to
respond to challenges facin g
medical education, resea rch
and patient care.
"This agreement is th e
final step in the creation of a

J

sol id foundation on which
Jewish Hospital, Barnes
Hospital and the School of
Medicine will build the
health care system of the fu
ture. And Barnes Jewish,
Inc. (BH) provides the ve
hicle for Jewish and Barnes
hospitals to deve lop this sys
tem in ways that maintain
th e highest quality patien t
care while reducing costs
and duplicative services,"
says Wayne M. Lern er,
D.P.H., Jewish Hospital' s
president.
William A Peck, M.D. ,
exec utive vice chancellor for
medical affairs and dean of
the School of Medicine,
says, "This agreement final
izes the es tabl ishment of
partnership s between the
medical school and its affili
ated adult teaching hospital s
- th e Jewish Hosp ital ofSt.
Louis and Barnes Hospital.
The platform now exists
from which the Medical
School and B1I can meet the
hea lth care challenges of the
future."
The agreement between
the School of Medicine and
Jewish Hosp ital provides for:
• the parties to establ ish a
new Joint Office of Clini
cal Affairs composed of
senior mana geme nt from
both organizations that wi II
work with the clinical
chiefs and hospital ex ecu
tives to se t and reach joint
goa ls for clinical care,
teac hing and resea rch;
• continuing Jewi sh
Hosp ital ' s independent re
search programs and its
residency and nursing
teaching progra ms;

• Jewish Hospital to share its
net reve nues with the
School of Medicine in or
der to partially compensate
the school for the costs of
the medical direction and
teach ing services provided
by the faculty, division
chiefs and department
heads;
• strong support of a medical
staff composed exclusively
of clinicians who will have

Sohel HOllored
urton Sobel, M.D. ,
professor of medi
cine an d director of
the cardiology division, re
cently received two career
honors: He was nam ed presi
dent-elect of the American
Professors of Cardiology
(APC) , a national organiza
tion devoted to exce llence in
fulfillment of th e clinical,
educational and investigative
responsibilities of aca demic
cardiology programs, and he
was presented with the 1992
Herrick Award from th e
American Heart Associa
tion 's Council on Clinical
Cardiology .
Sobel was named presi
dent-elect of the APC by the
group's 118 members, all of
whom are directors of aca
demic cardiology program s
around the country. He will
hold th e post for one year
from January I, 1993 , then
will serve as president for
one yea r, succeeding Yale
University'S Barry Zarut.
The prestigious Herrick
Award is given annually to
recognize a physician whose

B

full- or part-time faculty
appointments at Washing
ton University School of
Medicine .
The new agreement
serves as a master document
gove rning the broad terms of
the parties' affiliation. Addi
tional , subsequent negotia
tions related to spec ific
facets of th e new a ffi Iiation
wi II be conducted in the
co ming months.

rr)\~if'e
sc ientific ac hie vements have
contributed to the advance
ment and practice of clinical
cardiology. Sobel accepted

Burton Sobel, M.D.
the award on November 17
at the American Heal1
Association's annual scien
ti fic meeting . •

3

T"v() Shal''''
Wakenlan

Aw ru-. 1

T

wo scientists here
have been presented
with the Wakeman
A ward for Re sea rch in the
Neurosciences, John W,
Olney , M ,D" professor of
psychiatry and neuropathol-

aspartate, can have toxic ef
fects on cells in the brain and
spinal cord, Injury from
trauma or stroke and dis
eases such as Alzheimer's
cause the release of large
quantities of excitatory
amino acids and destroy irre
placeable brain and nerve
cells.
The Wakeman Award is
considered one of the most
prestigious in the neuro-

ders. Choi followed by pro
ducing glutamate excitotox
icity in cultured brain
neurons and clarifying mech
anisms by which glutamate
excitotoxicity can contribute
to neurological disorders.
"The contributions are not in
competition with one an
other, but are rather separa te
aspects of the sa me th eme
that complement one an
other," Olney says,
The Wakeman Award is
presented every two years.
It was established in 1972 by
Nancy D.W, Gardiner in the
memory of her husband,
William T. Wakeman.

LJltrasolllul
Spots Kl(ln(~y
()],S IrlU' tiUJIS
MOI~e Safel~
John W. Olney, M.D.

Dennis W. Choi, M.D., Ph.D.

ogy, and Dennis W , Choi,
M,D" Ph,D" Andrew B . and
Gretchen p, Jones Professor
of Neurology and head of
neurology , share thi s year's
award with Jeffrey C
Watkins, M,D. , professor of
pharmacology at the U niver
sity of Bristol in Bristol, En
gland.
The three were recog
nized for their work in the
area of excitotoxicity, The
word, coined by Olney, de
scribes the process by which
brain and nerve cells are Iit
erally stimulated to death by
the brain's neurotransmit
ters. Excitatory amino acids ,
particularly glutamate and

sciences. "It is a special
honor, for which I am very
grateful ," Choi says. " I hope
to join Drs. Watkins, Olney
and others in continuing to
contribute to the excitotox
icity field,"
For Olney, the award rep
resents official recognition
for the first three generations
of contributors to the field of
excitotoxicity, Watkins, he
says, provided the founda
tion by identifying how
amino acids alter the activity
of neurons. Olney later dis
covered the toxic effects of
the excitatory amino acids
and demonstrated their po
tential role in brain disor

4
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esearchers here have
applied the lates t ul
trasound techniques
to develop a safer method for
diagnosing kidney s tones
and other forms of urinary
tract obstruction,
Using color Doppler ul
trasound and conventional
X-rays, the investigators at
Mallinckrodt Institute of Ra
diology produced images of
blood flow in the kidneys
and of urine entering the
bladder to assess whether
urine made the journey from
kidneys to bladder success
fully. The approach may
help avoid the adverse drug
reactions that occasionally
result from the current diag
nostic test of choice, says

Lane Deyoe, M.D., a radiol
ogy fellow.
Currently , physicians di
agnose possible urinary tract
obstructions by using a plain
abdominal X-ray to look for
kidney stones and an intrave
nous urogram (IVU) to as
sess urine flow. For an IVU ,
patients are injected with a
contrast material and ab
dominal X-rays are made,
The contrast material pro
duces an image of the path
urine takes as it leaves each
kidney and travels through
ureters to the bladder. Ifan
obstruction exists, an IVU
may show the contrast agent
pooling up behind the block
age, says Deyoe,
The IVU is generally
quite accurate and safe,
Deyoe says, But in some pa
tients , the contrast material
causes adverse reactions
such as nau sea, vomiting,
irregular heart beat and , in
extremely rare cases, death ,
Mild to moderate reactions
affect two to eight percent of
pa ti ents; seve re , life-threat
ening reaction s occur in 0,0 I
percent to 0, I percent of pa
ti e nts , Deyoe says. In addi
tion , the test is not ideal for
pregnant women because it
exposes their fetuses to ra
diation and to the contrast
drug, he adds.
Deyoe and colleagues
evaluated 32 patients sus
pected of having a urinary
tract obstruction usi ng a
plain abdominal X-ray and
three ultrasound techniques,
They used IVU exams as the
standard for comparison.
With a traditional ultra sound
exam of the kidney , they
looked for urine pooling in

the kidney. They also ap
plied a technique called
pul sed Doppler to look for
decreases in blood flow to
the kidney, which can indi
cate a urinary tract blockage.
Third , the researchers used
color Doppler ultrasound to
look for "ureteral jets," the
regular spurts that normally
send urine into the bladder.
Color Doppler, ba se d on a
principle similar to police
radar, uses sound waves to
measure the speed of moving
materials.
The ultrasound approach
correctly diagnosed all com
pletely obstructed patients
and all patients who were
completely unobstructed. Of
14 patients with partial ob
structions, I I (79 percent)
were correctly di ag nosed.
There was one false-positiv e
result in one completely ob
structed patient Overall , the
tes ts were accurate in 28 o f
the 32 patient s (88 percent).
"We found th at the ultra
sound was very good at diag
nosing these obstructions.
The IVU is a good test, but
for patients who sbould not
receive the contrast material,
thi s gives us an option,"
Deyoe says.
Ultrasound , unlike the
traditional X-ray exams, also
gi ves physicians the capabil
ity of looking for othe r
causes of abdominal pain ,
such as appendicitis or gall
bladder disea se, he adds. The
ultrasound approach may be
especially valuabl e for preg
nant women , the elderly,
peop Ie who are allergic to
the contrast material and
people who have unhealthy
kidneys, he says .

Cullen Is Asso('ialt' Viee Cluuu't>llor Fur
Rt>sf~al"(~h: Lazarus l\anu!(l A.ssislanl [)~an
usan E. Cullen, Ph.D.,
has been appointed the
uni versity's associate
vice chancellor for research,
and Cath y J. Lazarus, M.D. ,
bas been named assistant
dean for student affairs at the
School of Medicine.
As the chief admini s tra
tor, Cullen coordinates a ll
ac tivities of the rese arch of-

S

interface with other univer
sityoffices.
" Sue Cullen brings her
faculty and resea rch experi
ence, as well as her knowl
edge of the research office,
to thi s important part of the
university's teaching, learn
ing and resea rch endeavors.
She ha s outsta nding creden
tials," says Edward S.

Susan E. Cullen, Ph.D.

Cathy J. Lazarus, M.D.

fice related to external su p
port for research, includin g
funding from federal and
state agencies, voluntary
health organizations and the
corporate sector.
The office helps faculty
find sources of supp011, pro
vides ass istance in the pro
posal submission process,
handles federal s ubcontra ct
ing, establishes prime con
tracts with indu strial
sponsors, provides some of
the university's compliance
functions and serves as an

Macia s, univers ity pro vos t.
Cullen is an immunologi st
who joined the faculty in
1976. In 1985 , she was made
a fu II professor in both the
Department of Molecular
Microbiology and the Oe
pal1ment of Genetics.
Lazarus, who in 1990 was
nam ed director of the Wash
ington University Medical
Campus Student and Em
ployee Health Servi ces, will
continue in that pos ition in
addition to her responsibi li
ties with the newly created

position of ass istant dean.
She assumed her new role
December I.
" Dr. Lazarus is a fine
mentor and clinician , in
tensely interested in student
activities," says William A.
Peck, M.D., executive vice
chancellor for m ed ical af
fairs and dean of the School
of Medicine. " Her many
talents will enhance our very
impo11ant and already fine
student affairs program."
In her new pos ition,
Lazarus will assist Patricia
L. Cole, M.D., associate
dean for student affairs, who
will take on the added role of
director of the Cardiac Cath
eterization Laboratory at
Jewish Hospital, part of
Washington Universi ty
Medical Center. Lazarus and
Cole will be respons ible for
arranging all student affairs
activities at th e medical
school such as graduation ,
orientation and other events.
La zar us, who is an assis
tant professor of clinical
medicine, will continue as
director of student and em
ployee health service, over
seeing administration of the
service and providing direct
pat ient care to m edical cam
pus students , including those
in the medical sc hool , gradu
ate school of biological sc i
ences , occupational therapy,
physical therapy and other
programs based at the
School of Medicine . •
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ohn P. Atkinson, M.D.,
and Jeffrey 1. Gordon,
M.D., have been
elected to the rank of fellow
by the American Association
for the Advancement of Sci-

J

macology and professor of
medicine, \vas named for his
studies on the cellular and
molecular biology of cells
that I ine the intestine and for
analyses of the enzyme N
myristoyltransferase (NMT).
Gordon's laboratory has
used a family of genes en
coding fatty acid binding
proteins as models to study
the atomic details of fatty

the title of dean of the Wash
ington University School of
Medicine as well.
Peck was named vice
chancellor for medical af
fairs and dean of the School
of Medicine in 1989 and is
the first person to serve in
the dual position. As dean,
Peck administers the aca
demic, research and patient
care activities \vithin the
School of Medicine. As ex
ecutive vice chancellor, he
guides and coordinates the
relationships between the
school and other organiza
tions and constituencies,
such as the affiliated hospi
tals, the National Institutes
of Health and corporations
and foundations. Peck also
serves as president of the

Washington University
Medical Center, which in
cludes Barnes, Jewish,
Cbildren's and Barnard hos
pitals and the Central Insti
tute for the Deaf.
"When the decision was
made to combine the
deanship and the vice
chancellor's responsibilities
into a single position, we
knew we would need a
leader with exceptional tal
ents in the areas of adminis
tration, education and
biomedical research," says
Danforth. "Bill Peck has cer
tainly proven to have that
mix of talents and has guided
the school extremely well
during a period of growing
expectations and chal
lenges." •

IuYesligalors Lool~ }'Ol" Gcnclie
Markers In Schizophrenia
John P. Atkinson, M.D.

Jeffrey I. Gordon, M.D.

ence (AAAS). The associa
tion bestows this honor on
members "whose efforts on
behalfofthe advancement of
science or its applications
are scientifically or socially
distinguished."
Atkinson, professor and
chairman of the Department
of Internal Medicine and
professor of molecular mi
crobiology, was named for
his pioneering research in
immunology, for exemplary
professional leadership in
the field of rheumatology
and for inspiring contribu
tions as a medical teacher.
Gordon, professor and
head of the Department of
Molecular Biology and Phar

acid-protein interactions and,
through the use of transgenic
mouse technology, to exam
ine the differentiation and
proliferation programs of
intestinal epithelial cells . •
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illiam A. Peck,
M.D., has been
named executive
vice chancellor for medical
affairs, according to Chan
cellor William H. Danforth.
Peck will continue to carry

R

esearchers at the
School of Medicine
have received a
$400,000 grant from the Na
tionallnstitute of Mental
Health to study the heritabil
ity of schizophrenia.
Steven O. Moldin, Ph.D.,
assistant professor of psy
chiatry, will evaluate 50
schizophrenic patients and
three family members to
study biological traits com
mon in patients and their
relatives who are not suffer
ing from the disease. All will
be tested for attention disor
ders.
"People with schizophre
nia tend to have trouble with
attention. If you ask them to

follow a moving object or
perform a task that requires
attention, they do poorly,"
Moldin says. "Their rela
tives, who might not have
schizophrenia, also tend to
have impaired attention.
With this study we are trying
to see how schizophrenia
and attention together are
inherited through the fam
ily."
Moldin will gather data
for the five-year grant from
inpatients at Malcolm Bliss
Mental Health Center and
Barnes and Jewish Hospitals
at the Washington University
Medical Center, where he is
an attending staff psycholo
gist. •

P4~"."ZOI

;\yioli A,nti f:hrjlelli
(-l.. norerl F'OI' Cunl ..ihllliulI~
arlos A. Perez, M.D.,
director of the Radia
tion Oncology Center
a t Washington Univers ity's
M a llinckrodt Institute ofRa
diology , has bee n awarded
the 1992 Gold Medal Award
from the American Society
for Th e rapeutic Radiologists

trol bone cell activity and
biologica l function.
The awa rd is given annu
ally for outstanding resea rch
in the field of orthopedics and
bone metabolism. Avioli is
Shoen berg Professor of Medi
cine, and Civitelli is assistant
professor of medicine . •

Carlos A. Perez, 111.D.

Louis V. Avioli, M.D.

and Oncologi sts (ASTRO).
ASTRO, the largest soci e ty
of radiation oncologists, ha s
giv en the aw a rd since 1977
to recogni ze outstanding
contributions to the field of
radi a tion oncology. Perez is
a mong th e youngest ever to
receive it.
Louis V . Avioli, M .D.,
and Roberto Civitelli, M.D .,
ha ve received the Kappa
D e lta A ward from th e
American Academy of Or
thopedic Surgeon s for their
outs ta ndin g contributions to
the fundamental understand
ing of tho se factors that con
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igh leve ls of in s ulin
an d insulin precur
sors may contribute
to ath erosclero s is in non
insulin-d ependent diabetic s
by di sruptin g their bodics'
built-in mechani sm for dis
so lving blood clots, accord
in g to inves tigators he re. A
better understanding of these
clotting disruptions ma y ge n

erate new approaches to
treatin g atherosclerosis
among diabetics.
The findings prov ide the
best ev idence to date Iinking
insulin to the high rate of
card iova scular di sease in
people with non-in su lin-de
pend ent diabetes (NlDDM)
- a disea se that affects 14
milli o n Am erican s, the re
searchers say.
Clinical studies have
hinted that overabundance of
insulin and its precursors
the substances from which
insulin is formed - might
accelera te atheroscl e ro s is in
people with NlDDM, hyper
ten s ion or obesity, says
David Schneider, M.D. He
a nd Jane t McGill , M.D., in
structor of medicin e, are lead
authors of the study.
In th e first of two studies,
Schneider a nd his colleagues
looked at in su lin 's effect on
endothelial cells, the cell s
tha t line blood ve sse ls. They
confirmed reports that insu
lin stimulates production of a
substance called plas mino
gen ac tivator inhibitor type I
(PAl-I). PA I-I interferes
with blood chemicals that
prev ent clot formation.
In th e second study, the
investigators mea sured PAL
I in 69 people : 34 with
NIDDM, 19 non-diabe tic
obese and 16 non-diabetic
lean volunteers. They found
that obese and diabeti c
peo ple had abnorma lly hi g h
lev e ls of PAL-I , findings tha t
confirmed past studies. The
researchers then went a ste p
further to see whether such
PAI-I level s a ltered the abil
ity to res pond to blood c lots.

They simulated a blood ves
se l blocka ge by apply ing
pressure to decrease circula
tion in an arm for 10 min
utes , then measured levels of
the natural clot dissolver
called ti ss ue-type plasmino
gen activator, or t-PA. Lean
peopl e responded appropri
ate ly , by produ cing the
hi g her leve ls oft-PA re
quired to brea k up the clot,
had it bee n rea I. Diabetics,
however, had no such re
sponse. Th e finding marks
the fir st time resea rchers
have shown a direct link be
twee n PAI-l levels a nd an
impaired response to physi
ologic stre ss in the same
group of people.
Th e studies sugges t that
diabetics may not respond
properly to microscopic
blood clots th at may form on
a re g ular basis, Schneider
says. "In each of us , a dy
namic equilibrium e xists be
tw ee n m ak ing clots and
di sso lving them. If there is
too much PAI-I present, di s
solution of clots may be im
paired. The effect of that
may be persistence or rec ur
rence of clotting, which can
exacerbate atherosclerosis,"
he says . •

CO""fJoelioll
n tbe legend accompa
ny ing th e photograph on
th e insi de front cover of
th e la st issue of Outlook
(Winter, 1992), Carlton C.
Hunt, M .D., and Albert Roos,
M.D ., were misid en tified as
Ph.D. s.
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Investigators Search For A Virus That Is

ax Arens, Ph.D., got an unexpected

by Jim Keeley
8

phone call last year as he sat in his
office. "Max," the unfamiliar voice
said, "this is Michael Whyte at Jewish Hospital.
Would you like to go fishing?"
Arens had never met Whyte, but a virologist in
an academic medical center with approximately
2,000 researchers becomes accustomed to calls
from scientists needing help in tracking viruses.
He accepted the invitation.

Rare and officially unnamed, a new disorder manifests itself in its victim's bones. Comparative X-rays (a normal left hip on the
left) demonstrate the disease's dramatic effect on bone density.
Michael Whyte, M.D., hoped that
Arens might help solve his puzzle.
Whyte's problem was that two patients
with an unusual skeletal disease had
been referred to him . Whyte proposed
the fishing expedition to pursue the
disease's origin.
In June 1990, Dennis Villareal, M.D.,
a fellow in the division of bone and
mineral diseases , had learned of a 27
year-old woman who later appeared in
Whyte's office complaining of severe
pain in her legs. Her referring physician
had taken X-rays that showed dense
bones. Her medical history was not
informative; almost everything appeared
normal , leaving Whyte few clues on
which to base a diagnosis.
Eight months later, a second patient
was referred to Whyte with remarkably

similar symptoms. The man also had
dense bones and complained of diffuse
skeletal pain that had plagued him for
two years.
Whyte was perplexed. In the span of
a year, two patients with dense bones
had come to his office complaining of
severe pain. Lab tests seemed nearly
normal; they did not fit the standard
profile of any known bone malady , and
previous doctors had been unable to
diagnose the exact source of their pain.
The patients had come to Whyte, a
professor of medicine, hoping that he
and other bone experts at the School of
Medicine could find the cause of their
mysterious ailments.
At first, there was no hint that the two
cases were even related. But after
persistent work, Whyte uncovered a few

tan tal izing clues that these two patients
share a single, rare disease. Past X-ray
studies showed that years earlier, both
patients had normal skeletons. Studies
by musculoskeletal radiologist, William
A. Murphy, Jr., M.D ., professor of
radiology, and bone pathologist, Steven
L. Teitelbaum , M.D., Wilma and
Roswell Messing Professor of Pathol
ogy, showed that not only were the
patients' bones growing denser, but they
were being built up and broken down at
twice the normal rate.
The studies didn ' t explain the cause
of the abnormal bone growth, but they
did provide the reason for the patients'
severe pain. Whyte surmised that as the
bones thickened and expanded, pain
fibers anchored at the bone surface
stretched and fired a pain signal. The
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Michael Whyte, M.D., and William Murphy, M.D., are among collaborators tracking down the origin and cure for a newly
identified disorder that accelerates bone growth.
dramatic bone production probably
caused the pain fibers to fire often.
With the pain partially explained,
Whyte began to consider the nature of
the prodigious bone formation. The
patients' histories offered a clue: Both
patients had been intravenous drug
abusers who had shared needles with
others. Whyte saw that their lifestyles
could have put them at risk of infection
from viruses that may have been passed
via contaminated needles. He decided to
call Max Arens to see if Arens would
test his patients' blood for suspicious
viruses.
Whyte also recalled reports suggest
ing that viruses may infect bone cells
and cause dramatic bone thickening in
other conditions. It occurred to him that
perhaps the tremendous bone growth in
his two patients also was caused by a
virus.
In fact, the laboratory tests showed
evidence of Epstein-Barr virus and
hepatitis C virus in both patients. But the
fishing trip that Whyte proposed to
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Arens snagged no evidence of Whyte's
prime suspect, a retrovirus that can
incorporate its genetic information into a
host's DNA. As Arens had feared, they
had reeled in more questions than
answers. But, like a good fish story, the
tale was getting more interesting all the
time.
Based on negative virology tests,
Whyte proposed a radical notion:
Suppose hepatitis C virus or some
unknown virus accidentally tripped the
bone growth switch in these patients.
This rate of new bone growth and
generalized skeletal thickening appeared
to be a new syndrome associated with
intravenous drug use. Uncovering the
cause of the disorder, Whyte says, could
conceivably help people with osteo
porosis who would benefit from reacti
vating the "on switch" for bone growth.
Before leaping to the concept of viral
transmission, Whyte had carefully ruled
out the possibility that these patients had
a known bone disease. His review of the
medical literature turned up several

diseases that can increase bone mass, but
none was similar to his patients'
condition.
Osteopetrosis - the name means
"petrified bones" - is a rare disorder
that often has a genetic origin. Research
ers understand that this disorder is
caused by defective bone-removing
cells. Bone is constructed in layers, each
layer radiating from the center outward
like the rings of a tree. Construction is
well regulated by at least two different
cell types: osteoblasts and osteoclasts.
Osteoblasts add layers to bone. They are
in constant communication with osteo
clasts, cells that chew away bone and
recycle some of its building blocks for
future use. Osteopetrosis is caused by a
cessation in the orderly breakdown of
bone. The layers of bone continue to be
stacked one on top of another with no
dismantling or recycling. The result is
bones that increase in size and density.
Bone biopsies of the two patients
excluded this disorder.

Paget's disease, another ailment that
spurs dramatic bone thickening, is more
common than osteopetrosis, afflicting
nearly 15 percent of the over-65 popula
tion. It is a "patchy" disorder, Whyte
says, affecting different bones in
different people. Some people with the
disease may have an enlarging hat size,
because the bones in their skull become
thicker. Others may notice bowing of
their legs, since the affected skeleton is
actually soft. Neither of the patients
showed classic signs of Paget's disease.
These patients' bones were gaining
mass fast. The average human receives a
new skeleton once every eight years. His
patients, Whyte says, could probably
accomplish the same feat in half that
time .
Osteopetrosis and Paget's disease
seemed to be excluded as the cause but
were not a dead end . The two disorders
share more than their ability to increase
the density of the skeleton. Reports in
medical journals provided evidence that
Paget's disease and osteopetrosis may be
caused by viruses. The evidence for
these disorders is preliminary, Whyte
cautions, but there is speculation that
canine distemper virus could cause the
dense bones of Paget's disease.
Osteopetrosis can be induced in chick
ens by certain strains of avian leukosis
virus. Whyte had these findings in mind
when he asked Arens to be his fishing
partner.
Arens' virology report didn't support
the notion that a known virus was
causing the problem, unless hepatitis C
is the culprit. Hepatitis C is capable of
causing many symptoms, but no one has
shown that the virus can switch on bone
production, says Arens.
Arens admits that after Whyte'S
initial phone call he thought he would do
the virology work and that would be the
end of it. Now, a little more than a year
later, he and Whyte are still fishing for
the cause of this mysterious disease.
"Dr. Whyte is very persistent," notes
Arens.
Their discussion of the disorder is
qualified by "ifs" and "maybes." The
two scientists do not say the bone
growth is the work of a virus - they
have no proof. But suspicions are that a
virus of some type is a prime candidate.

If the cause is viral, Arens suspects it
will be a long time before that virus is
isolated and identified. "J think it's
absolutely reasonable at this point to
suspect an unknown virus," he explains,
"but identifying the virus is not without
its problems." Arens speaks from
experience. Several years ago, while on
the faculty at St. Louis University
School of Medicine, he was asked by a
local company to help identify a virus

Medical school virologist Max Arens,
Ph.D., investigates the possibility ofa
viral origin for the disease.
that had run loose in its laboratories,
contaminating hundreds of liters of cell
cultures. "We isolated the virus, ex
tracted the DNA, and discovered it was
an adenovirus the likes of which no one
had ever seen before. But finding and
identifying the virus took a lot of work."
In August 1991, Whyte took his
speculations on the road. He presented
his findings concerning the two patients
at the 13th Annual Meeting of the
American Society for Bone and Mineral
Research in San Diego. "Those who
came by to see the poster were as
tounded by the density of the bones," he
says. Despite the interest of researchers
at the meeting, it didn't elicit the
response Whyte had wanted. He'd hoped
to hear that there were more cases like
the two in St. Louis. "I would have
thought that with the frequency of
intravenous drug abuse, this disorder
would be more common than just two
patients who came to St. Louis. But I
think the publication describing these

patients will take time to percolate in the
medical community," he says.
While writing on the subject, Whyte
found what he thinks is a third case of
this syndrome. The published report
details a young woman with a history of
intravenous drug abuse who developed
the same type of painful diffuse bone
thickening with increased skeletal
turnover. Whyte writes: " It seems
unlikely, but remains possible, that the
intravenous drug abuse of our two
patients and the similar previously
reported patient is merely coincidental."
Whyte and Arens acknowledge that
pinning down the cause of this enigmatic
syndrome is going to take time . Whyte
believes it is a new syndrome and
speculates that it is associated with
intravenous drug use. Arens remains less
convinced, preferring to let the science
speak for itself.
Whatever the cause, the two patients
with this painful bone condition have
benefited from their visits to the School
of Medicine. Whyte and his colleagues
were able to apply lessons learned from
their research on bone metabolism and
Paget's disease to stop the accelerated
bone growth and the attendant pain. "We
recognized that their dense bones were
caused by rapid bone formation and
rapid breakdown, much like Paget's
disease," Whyte explains.
The researchers knew from basic
research done at the School of Medicine
that Paget's disease is probably caused
by faulty communication between
osteoclasts and osteoblasts. Experimen
tal work showed that quieting the
osteoclasts, or bone-breaking cells, with
the hormone calcitonin would also quiet
the osteoblasts, the bone-forming cells.
"We were hoping the same thing would
happen in our two patients," Whyte says.
There was danger involved in the
therapy. Whyte explains: "Say you're
rapidly breaking bone and rapidly forming
bone but the net effect is that more bone is
accumulating. If you shut off the bone
breakers and the bone formers keep going,
these people could get worse." Fortunately
that hasn't happened, and now "both
patients are feeling much, much better,"
Whyte says . •
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en years ago, medical scientists could
identify some of the thousands of
disorders that have their origins in
imperfect genes, but they had no way of
knowing where the responsible genes
were, and they possessed little grasp of
the protein products that genes are
responsible for making.

Three Examples
ofPotential
Gene Therapy

by Steve Kohler
12

Today, medical science is at ground
zero in an explosion of knowledge about
human genes, their products and the
maddeningly complex ways in which
they can go wrong.
The leap into tomorrow requires
bringing our deepening ken of genetics
to patients whose genes malfunction.
Gene therapy, as such science is called,
proves to be even more daunting than
unraveling DNA. In addition to locating
and cloning the genes involved, re
searchers must gain control over the
DNA sequences that signal genes to
express their messages and other
regulators of gene behavior that may be
spread out along the chromosome. Then
they must devise delivery systems to get
enough "good" genes into place so they
can do the work that "bad" genes fail to
do.
Recombinant theory is already being
used to create medicines that can restore
health when faulty genes don't produce
a necessary protein. And investigations
are rapidly advancing gene therapy's
most ambitious vision, in which clini
cians will replace genes inside specific

cells, compl ete with precise control.
Three examples of gene therapy research
being conducted at the School of
Medicine show the possibilities:

•

01-gan s ystem: Eye
Application: Retinitis pi gmentosa
Researchers: David Leib, Ph.D., and
Jay Pepose, M .D., Ph.D.
People who inherit the genetically
tran sm itted disease retinitis pigmentosa
( RP) frequently lea rn of their condition
when th ey notice their ability to see the
stars is dwindling. The di sease - a slow
degeneration of the eye's retinal cells
begins at the periphery of the retina and
most often affects the orga n' s more
sensitive light recep tors, th e rods, more
than it does the con es, says ophthal
mologi st Jay Pepose, M.D., Ph.D .
Those affected usu ally lose the ir
peripheral vision first and lea rn just how
dependent th ey are on the edges of their
sight for navi gating. The di sease
progre sses to take a ll but the 10 per cent
of vision in the center - tru e tunnel
vision - at which point a sufferer is
lega lly blind. Central vision also may be
affected in some forms or stages of the
disease.
Not an uncommon probl em, most is
known a bout the autosomal dominant
form, in which the degeneration ha s
been identified as bein g a function of a
defi c iency in th e gene that carries the
code for a protein named peripherin.
For researc h purposes, a strain of
mice called rds (for retinal degeneration ,
slow), has been bred , and both the
defective rds gene and its correct
counterpart ha ve been c loned and
seque nced . Researchers at Southwestern
University have created transgenic rd s
mi ce that possess the correct form of the
rds gene . " The condition is reversed
compl ete ly in those mice; the degenera
tion is resc ued," Pepose says.
But tran sgenic humans are not
po ss ible, "so we need a de livery syste m
for the co rrect ge nes," Pepose explains.
I n their search for a way to del iver
therapeutic genes into the cell s of the
eye, Pepo se and his colleague, Dav id

One ofthe gelle therapist's helpful tools, beta-galactosidase expressed by all
inserted gelle, reveals its presence ill telltale blue. Here, the gene was attached to a
neuron-specific promoter and illstalled in nerve cells using the herpes virus as a
vehicle.
Lei b, Ph.D ., have hit upon the he rpes
simplex viru s, a vehicle well suited to
the job.
" He rpes simplex will infect almost
any ce ll type," Leib says, "but it only
persists in a neuron ," or nerve cell. The
reason is most likely that nerve cells are
post-mitotic; that is, they are no longer
di vi ding. The lack of ne uronal cell
division allows the virus to persist in
those cells for the Ii fe of th e hos t.
When herpes virus invad es a neuron,
such as a retinal cell , it circularizes and
e nters a late nt state. "B ut that's not a
passive state," Leib points out. " It sti ll
generates a lot of RNA. "
" The herpe s simplex v iru s makes a
great Trojan horse," says Leib . "We
incorporate our therapeutic ge ne into the
virus' chromosome, then infect the

neural cell s of the eye." Once th e altered
viru s infects a retinal cell , it ma y remain
late nt over time, expressing the thera
pe utic protein th at its added gene
encode s.
Th e researchers use a crippl ed herpes
virus that is made safe by deletin g a
viral gene necessary for replication. The
vira l particles remain infectious , but
th ey cannot make more like themselves,
becau se the recipe is missin g. Pepose
and Leib go farth er st ill in manipulating
the viru s to do their work. They add a
promoter from yet another ge ne - that
fo r rhodop sin , the protein that allows
light to be converted into electrical
impul ses in the eye. Common to retinal
tissu e and powerful, the rhodops in
promoter charges the th erape utic gene
with added ac tivity .
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Organ system: Liver
Application: Serum protein deficiencies
Researcber: Katherine Parker Ponder, M.D.

David Leib, Ph.D., (seated) and Jay Pepose, M.D., Ph.D., work to apply gene
therapy to the treatment of retinitis pigmen tosa, in which the eye's light-sensing
cells degenerate as a result of a gene flaw.
And they delete the vims' vhs (for
virion host shutoff) gene. Normally, that
gene slows a host cell's production of
protein so that the vims can subvert the
cellular machinery for its own use. "It
shuts off the cell and kills it," Leib
explains. "By knocking out the vhs gene,
we reduce damage to the very cells
we're wanting to fix ."
How is the cocktail of altered herpes
virus with its added therapeutic gene
delivered? Via direct application to the
target cells. A tiny injector is inserted
through the clear cornea of experimental
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animals and inserted into the subretinal
space. The "electric thumb," a device
engineered for the purpose, gently
delivers a microliter of virus in solution
each time a foot pedal is depressed.
Pepose says the de Ii very system can
treat 90 percent of the retina in an
application.
Will the genes delivered via the
herpes virus produce the missing protein
and rescue sensory cells in the eye?
Experiments are in progress to answer
that question.

Many genetic diseases involve
proteins made in the liver: Most of the
coagulation factors in the blood origi
nate there; the apolipoproteins, deficien
cies of which can lead to atherosclerosis,
are expressed there, and the complement
proteins of the immune system are
produced in the liver. That wealth makes
the system of particular interest to
Katherine Parker Ponder, M .D., who
concentrates her efforts on developing
gene therapy there.
In pm1icular, Ponder in vestigates the
protein alpha-l antitrypsin, a genetic
deficiency of which can result in emphy
sema, and protein C, a blood coagulation
factor. Working with crippled retrovirus
to del iver correct genes to liver cells,
Ponder is showing that it's possible to
get long-term expression of serum
proteins, but hurdles remain to be
overcome.
The retrovirus has several advantages
as a delivery system to bring therapeutic
genes to liver cells, Ponder says. First, it
is relatively safe. By deleting the genetic
information the virus needs to package
copies of itsel f, Ponder takes away its
ability to remain infectious . She then
installs the same packaging information
in a cell line. When the vector DNA is
transferred into the cells that are making
empty retroviral particles, its RNA can
be packaged into a virus capable of a
single round of infection. In that way,
researchers make enough viral media for
their purposes, yet mn no risk of
multiple rounds of infection.
Second, a retrovirus has the capacity
to integrate into the genetic material of
the cells it infects. That means that it can
deliver its cargo gene directly to the
genetic machinery of those cells that
require it. That DNA will be maintained
there for the long term.
The size of the cargo, however, is
limited ; a certain amount of space is
required for the information that lets the
vims infect cells and integrate into

A section of liver from a laboratory animal demonstrates the ability of researchers
to deliver genetic payloads. The liver was treated in vivo with a retrovirus carrying
an inserted gene. The gene expresses a protein that enables a cell hosting the gene
to be stained; here, blue cells have been genetically modified.
cellular DNA. But Ponder is working to
find the smallest amount of viral infor
mation necessary so that the genetic
payload she wants to deliver can be as
large as possible.
Using the retrovirus delivery system,
Ponder first explored an ex vivo method
of gene therapy in which cells were
removed and treated in tissue culture
before being reintroduced. Several
difficulties plague the approach. Cells
must be manipulated to get them to
repl icate, necessary before a retrovirus
can infect them. Ponder says only about
two percent of the total liver mass can
be re-injected once it has been treated,
"or you clog up the works." And the
technique is time consuming.
A second approach, done in vivo,
addresses these limitations. Ponder
explains that the liver is unusual because
the structure of the blood vessels there
a Ilows contact between large particles in
the blood and liver cells. Thus, virus
particles can be infused directly.
Ponder and her colleagues remove a
large pOl1ion of the liver in lab animals
to stimulate cell growth and replication
in what remains. When that replication
peaks, about 24 hours after surgery , she
injects the genetically altered retrovirus
into the portal vein. The researchers then
have only five minutes in which to work,
after which time oxygen deprivation
causes liver cells to die.
"About one percent of the cells are
infected by the virus," Ponder says. She

would like to achieve better penetration,
and work proceeds to produce higher
levels of infection. But with the in vivo
method, investigators can treat 12
animals in two days instead of just the
one per week they could do using the ex
vivo approach.

Ponder explores the possibility of
getting each infected cell to overexpress
the desired protein. Expression level is
largely a function of the gene promoter
installed with the desired gene. That
promoter also affects the length of time
for which the protein will be produced.
"We now have used a gene promoter
normally expressed in all cells, installed
it upstream of our gene for alpha-I
antitrypsin and achieved long-term
expression of the therapeutic protein ,"
Ponder adds .
"We get reliable levels of protein
production for six months," Ponder says.
"While we haven't reached therapeutic
levels for alpha-I antitrypsin deficiency,
we've been using that serum protein
primarily because we can check our
results with a simple assay. The same
level of expression in other genetic
disorders, such as hemophilia, would be
therapeutic. We're now working on
protein C deficiency, and we ' re getting
close to the genetic disease ballpark,"
Ponder says.

Katherine Parker Ponder, M.D., explores the potential ofgene therapy in producing
therapeutic levels of serum proteins.
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Timothy J. Ley, M.D., (seated) directs research into the reactivation ofgenes that
normally are switched off at birth. Working with him are graduate students Bruce
Hug and Mike Ulrich (right).
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Organ system: Blood
Application: Hemoglobinopathies
Researcher: Timothy J. Ley, M.D.
The expression of genes is not
constant; mechanisms exists to switch
genes on and off. Timothy Ley , M .D., is
working to understa nd one such mecha
nism. Hi s aim is to be able to open a
particular switch.
At about the time of birth , human s
normally change from producing one
form of hemoglobin , the fetal form, to
producing another, th e adult form, Ley
explains. At the changeover, the gene for
fetal hemoglobin is sw itched off and the
gene for the adult version is switched
on. All too often, however, the adult
version of the oxygen-carrying globin
protein is flawed - either misshapen or
so reduced in amount as to cause serious
health problems, depending on the gene
flaw.
When the adult hemoglobin is
malformed, one re s ult can be sickle cell
anemia. A defect that causes too little
adult globin is called beta thalassemia.
" An obvious strategy for treating these
hemoglobinopathie s," Ley says, "is to
reactivate the fetal globin genes." The
approach is especially attractive because
a number of adults continue to express
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fetal hemoglobin, and they s uffer no ill
effects from what is called their Heredi
tary Persistence of Fetal Hemoglobin
(HPFH).
"There is good reason to push
forward," Ley says. Sickle cell patients
in some parts of the U.S . experience
annual health care costs that can average
as much as $50,000 eac h. Patie nts suffer
intermittent painful c ri ses when mis
shapen hemoglobin molecules literally
get stuck in blood vessels and rob tissues
of oxygen. The I ives of sickle cell
patients are shortened.
Tha lassemia is widespread, partic u
larly in Mediterranean and As ian
countries. Its standard treatment in
volves regular blood trans fu sions
beginning s hortly after birth . Iron
removal therapy is the only way to lift
the burden those transfusion s bring, and
patients can expect to live only into their
30s or perhaps 40s. Bone marrow
transplants have been used with s uccess ,
but must be done at an early age, and
Ley raises the ethical question of
whether a pre sc hooler can give truly
informed consent to a procedure that
carries a five to 10 percent ri s k of
causing hi s or her death.
So gene therapy holds promi se. But
re-activating one pair of genes among
the body's 100,000 is easier to explain
than to do. Ley has been involved in
work to find a pharmacologic agent that

will safely re-activate fetal hemoglobin
genes. Several have been tried, begin
ning with 5-azacytidine about 10 years
ago and continuing to recent, widely
reported work with butyrate compounds.
Some of these drugs insult the bone
marrow so that it begins to make more
fetal hemoglobin when it recovers.
Others, origina lly cancer drugs, block
the methylation of DNA on the theory
that unmethylated fetal globin genes are
more active.
"But none of these agents wil I be the
cure," Ley says candidly. "You can ' t get
comfortable using them in children
when you don't know the effects 30 or
40 years down the road. What assurance
do we have that we're not also activating
an oncogene that causes cancer? If you
blindly manipulate blood cell ' program s '
and you're wrong, you ' re go ing to get
another problem , perhaps worse than the
one you started with," he says .
A complicated alternative , Ley says,
is first to remove some of the patient's
bone marrow and purify the stem cells
(from which aU blood cells are derived).
Stem cells account for perhaps one in
every 10,000 cells in the bone marrow .
Into those cells, researchers would the n
so mehow deliver normally regulated
globin genes before destroying the
disea sed marrow and installing the
corrected version.
Several major problems must be
confronted before that approach can
work. Ley says that it is not yet possible
to fully identify stem cells, and the
genetic therapy would have to treat
every one to be effective. " Perhaps most
difficult," he says, " is that the gene you
transfer has to be perfectly regulated. If
it doesn't make enough globin, you
haven't solved the problem. If it makes
too much, you've created what's called
alpha thalassemia , another destructive
disease. So the regulation has to be
precise. And that' s a tall order right
now."
"Still," Ley says, " that would be the
very best method." And so researchers
continue to purs ue means to overcome
the hurdles that stand in the way of
replacing bad genes with good ones . •

Spiral CT Improves Upon The Standard
by Juli Leistner

omputed tomography, or CT, has
earned its place as a clinically
[
valuable exam, but sometimes
the bread-slice images it provides are
not enough. Small abnorma lities may lie
between slices and remain undetected.
Others may be obscured by the plane of
view. And if the original slices do not
meet diagnos tic needs, the only option is
to sca n the patient again.
Now a new twist on conventional CT,
called spiral CT, is giving radiologists
and their colleagues a clearer window
into the human body. Hail ed as a major
advance in imaging, spiral CT reduces
th e hit-or-mi ss problems of conventional
CT, helps radiologists generate more
diagnostically powerful images, and
open s up new app lications as well.
For a conventional CT exam, a donut
shaped structure called the gantry rotates
an X-ray beam once around the patient
for each slice. For the next slice, the
gantry must be rotated back to its
original position and the table moved
forward in a carefully controlled
increment. A computer assembles a
cross-sectional im age after each scan.
Conventional CT has several draw
backs, explain s Jay H e iken, M.D .,
associate professo r of radiology and co
director of the body CT sec tion at
Washington University ' S Mallinckrodt
Institute of Radiology. One of the
biggest problems comes from respiratory
motion. Patients mu st hold their breath
during each scan to minimize motion; if
breathing is inconsistent from one slice
to the next, a small lung or liver lesion ,
for exampl e, might be mis sed, he says.
And, becau se the exams take several
minutes to complete, it is sometimes
impossibl e to collect all of the data
during the limited tim e when contrast
materia 1 provides the be st enhancement.
Also, the computer only holds data for
each slice; "If there is something in
between that needs to be imaged, we
have to rescan the patient," Heike n says.
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Stuart Sagel, M.D., and Jay Heiken,
M.D.
Spiral CT eliminates many of these
problems, Heiken says. Mallinckrodt is
one of the first sites in the country to
evaluate it. Investigators Michael
Vannier, M.D. , professor of radiology
and chief of the clinical research
division ; Stuart Sagel , M.D ., professor
of radiology, chief of the chest radiology
section and co-director of the body CT
section; James Brink, M.D ., assistant
professor of radiology , and others have
studied the technology for the past 18
months.
The secret to its power is continuous
scanning. An innovation called slip ring
technology allows the X-ray tube and
detectors within the gantry to spin
around the patient continuously as the
table glides forward. Because the table
travels during the scanning process, the
recorded X-rays plot a spiral course
through the body instead of a circle . A
computer stores raw X-ray data as one
volume, a three-dimensional memory of
the entire scanned area. The machine
speeds through a complete exam - of
the chest, for example - in about 30
seconds.
Because spiral CT is so fast, scans are
accomplished in a single breath-hold ,
eliminating respiratory motion problems.
The speed also means radiologists get
better diagnostic information, because
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they can do the entire scan when
contrast enhancement is at its peak,
Heiken says. In addition, they can often
reduce the dose of expensive contrast
material by approximately 50 percent in
chest scans and 25 percent in abdominal
scans without reducing image quality.
After a scan , the computer can
construct a set of slice images at any
interval the radiologist chooses, typi
cally from 2 to 10 mm. [fnecessary, the
radiologist can go back to the com
puter ' s data set and generate thinner
slices even after the patient has gone
home. It also is possible to compose
three-dimensional images and images in
any plane; when a transaxial cross
section is di fficult to interpret, an image
reconstructed in a longitudinal plane
often provides more information, Heiken
says. Multiplanar and 3-D images were
possible with conventional CT, but
inconsistencies from slice to slice
limited their quality, he adds.
Although spiral CT is still considered
investigational, clinical studies are
uncovering its practical benefits. Studies
show spiral CT finds more small lesions
in the liver than conventional tech
niques, Heiken says . At Mallinckrodt,
spiral CT is used routinely for exams of
the pancreas and for many exams of the
neck, chest and abdomen. "We are
generating diagnostic images with spiral
CT that were not possible before.

to

These bone scans were produced using
spiral CT from data collected in jive
minutes instead ofthe usual 20 min
utes, with radiation dosage reduced by
60 percent.
Because we can reconstruct images at
arbitrary intervals and we avoid respira
tory misregistration, we can pick up
lesions that we might otherwise miss,"
he explains.
Spiral CT also measures lesion
density more accurately - important for
deciding whether lesions are malignant,
Heiken explains. Spiral CT's flexibility
assures that radiologists can get slices
through a lesion's center for the most
accurate density reading, he says.
Spiral CT also may provide a safer
alternative to certain invasive imaging
exams. A recent clinical study by Brink
found that spiral CT rivals the gold
standard, cholangiography, for diagnos

On the left, a conventional, invasive
arteriogram. On the right. a 3-dimensional,
color-enhanced reconstruction produced via
spiral CT. The spine is in green; the left
carotid artery is in yellow, showing the
blockage ofthe internal carotid that should
supply oxygen to the brain. The right
carotid artery, in red and not blocked, shows
both branches.

ing bile duct obstruction. Similar
benefits are possible for imaging blood
vessels that suppl y the kidneys, Heiken
says. Preliminary work shows spiral CT
ma y be va luable for im ag ing blockage
and narrowing in the carotid arteries, the
vessels that lead from the aorta to the
head, says Christopher Moran , M .D.,
assistant professor of radiology. He uses
scan data to generate 3-D color images.
"The information they provide is similar
to angiograms ," he says. Spiral CT also
shows promise for imaging aneurysms in
the head , he adds.
Kevin McEnery, M.D., instructor of
radiology , is app lying spiral CT to bone
fractures. He a nd Anthony Wilson,
M.B., Ch.B., associate professor of
radiology, and William Murphy, M.D .,
professor of radiology, are among the
few researchers anywhere studying this
app lication. "Conventional CT is used
when complex fractures are difficult to
accurately assess on plain X-ray or when
clinicians need more detailed infonna
tion regarding the fracture," McEnery
says. " For musculoskeletal CT imaging,
when we want to create high quality, 3
D ima ges or multiplanar reconstructions,
ma ny thin sections are necessary." With
standard CT, the exam could take 20
minutes or longer. "A patient who is in
pain usually can't be expected to hold
still that long," he says. Even subtle
movements cause misalignment of the
slices and degrade the images.
"We are excited about spiral CT. We
can shorten examination times, reduce
the radiation dose to the patient and
obtain better data because there is much
less chance of a patient moving during
an examination that lasts only 30
seconds," he says.
Another likely application will be
helping surgeons zero in on targets with
3-D and multiplanar images. It also may
benefit children, traum a patients and
others who have difficulty following
breathing instructions , Heiken says. And
short scan times are a plus for unstable
patients, McEnery adds . " As soon as the
scan is done, the patient can go right
back to intensive care, even though we
still are working on the exam at the
computer," he says.
Washington University is one of five
schools advising spiral CT's developer,
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James A. Brink, M.D.
Siemens Medical Systems, about future
refinements. Studies by Brink and others
are helping define the technical param
eters that generate the best results. And
Vannier is developing better computer
algorithms to turn raw scan da ta into
meaningful pictures.
According to Vannier, in the future it
is likely that spiral CT will replace the

conventional method , and Mallinckrodt
is embarked on a long-term , cooperative
development plan to refine and improve
CT imagin g . " Eventually, this will be
the way routine chest and abdominal CT
is done. I would estimate that within five
to 10 years, all major medical institu
tions will be using spiral CT routinely
for body imaging, " Heiken predicts . •

Black arrows mark a leiomyosarcoma arisillg from the wall ofthe inferior vella
cava (yellow arrows). The large organ is the liver. III the left image, reformed from
a stack of cOIII'entional CT slices, the information is less thall clear because at least
100 seconds and several breaths were required to collect the data. In the spiral CT
image 011 the right, spiral slices were gathered ill a single breath-hold, reducing
misregistratioll.
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n October of 1992, Edwin Krebs, M.D. '43, shared the Nobel Prize in

Physiology or Medicine for research on reversible protein phosphoryla

tion, a crucial process that regulates many enzymes and greatly affects cell
growth and differentiation. This most recent laureate began his distinguished
career 47 years ago in the laboratory of Carl and Gerty Cori, who themselves
shared the 194 7 Nobel Prize. The connecting link is a rare intellectual
phenomenon: a generation of Cori-inspired research excellence that has
flourished for nearly 50 years.
Krebs belonged to a group of brilliant
young scientists who launched their
careers under the Coris' auspices.
Among them, Krebs and the late Earl
Sutherland, M.D . '42, started research as
medical students. While Sutherland
assisted the Coris, Krebs worked in
Philip Shaffer's laboratOlY and later held
a postdoctoral fellowship with tbe Coris
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from 1946 to 1948. Like Sutherland,
who won the 1971 Nobel Prize for
discovering cyclic AMP, Krebs followed
a line of inquiry clearly opened by the
Coris' research.
Another alumnus of what might be
called "the Cori School," Arthur
Kornberg, a 1969 Nobel laureate for
research on DNA replication, described

their laboratory as, " a haven for ambi
tious, gi fted people from all over. ..right
after the war it was the liveliest enzy
mology lab in the world ." Yet, he notes
regretfully, "My students are now totally
unaware of the work and spirit of Carl
and Gerty Cori and of their guiding
influence on my generation of biochem
ists. "

Carl and Gerty Cori are pictured in their laboratory on October 4, 1947, at the time that they won tire Nobel Prize. Their
tremendous illfluence cOlltinues to reverberate through tire scielltific community.

Krebs' 1992 prize is the most recent
sign of the Coris' guiding influence.
They generated future research excel
lence by nurturing young scientists in an
extraordinary laboratory environment.
Though Gerty Cori died in 1957 and
Carl Cori in 1984, their scienti fie legacy
remains vibrant. They are among those
few scientists to achieve two kinds of

intellectual immortality - not only
through their own discoveries but
through those of their students. By both
measures, the Coris' record is remark
able.
Their collaboration began when they
were medical students in Vienna, where
they received medical degrees in 1920.
In what Carl Cori later called "the

doctors' dilemma," they realized that
post-war prospects for finding two good
positions in the same place were poor.
The years 1920-21 were a time of near
starvation in Vienna; while working as a
pediatric intern, Gerty Cori developed
symptoms of vitamin A deficiency.
Although Carl Cori managed to get a job
in Graz, he later described the atmo-
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Edwin Krebs received the Nobel
Prize last year. He was a research
fellow in the Department of
Biochemistry from 1946 to 1948
after receiving his medical degree
from the school in 1943.
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sphere there as "very disturbing." To
be hired, he had to prove Aryan descent.
Even experimental animals were hard to
obtain. He recalled: "I was the only
person.. .in a position to do experimental
work ... because my father...had been able
to send me a shipment of frogs. These
were kept in an aquarium under lock and
key and were responsible for my coming
to the United States." In 1922, an
American laboratory director became
interested in his studies and offered him
a position at the New York State
Institute for the Study of Malignant
Disease. Gerty Cori arrived six months
later and went to work in the pathology
department.
Carl and Gerty Cori's coUaboration
on carbohydrate metabolism began
shortly after their arrival, but they soon
encountered institutional obstacles to
working together. In a memoir, Carl
Cori recalled that, at one point, his wife
faced being fired "unless she stayed in
her room and stopped working with me."
When he decided to consider a job
elsewhere, Gerty Cori was taken aside
and told "she was standing in the way of
my career, and that it was un-American
for a man to work with his wife."
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Nonetheless, they persisted in working
together.
In 1931, their most fruitful years
began in the Department of Pharmacol
ogy at the School of Medicine. Despite
nepotism rules then in force, Dean Philip
Shaffer was wise enough to welcome
them as a team. As head of pharmacol
ogy, Carl Cori carried major administra
tive and teaching responsibilities.
Nonetheless, he continued research with
Gerty Cori (who received an appoint
ment as research fellow). He was well
aware that, as he later put it, "a most
exciting period in biochemistry had
begun to unfold ... all previous expecta
tions about the rate of development of
biochemistry were surpassed."
The Coris played a leading role in
that accelerated development. Between
1930 and 1935, they published a series
of papers analyzing what became known
as "the Cori cycle" - elucidating the
mechanism of blood glucose regulation.
While their work opened up several
other areas of research, a decision to
focus on glycogenolysis proved wise, for
it was the most fruitful field of study.
Arthur Kornberg has provided a
penetrating description of their ap

proach: "Carl and Gerty had the experi
mental gifts and wisdom to extend
physiological studies of whole animals
and organs to crude cell ex tracts and,
finally, to purified enzymes ... while
teaching themselves and their students
how to examine the molecular shapes
and operations of enzymes, they never
relinquished their devotion to under
standing the function and hormonal
control of enzymes in the intact animal."
In 1947, the Coris shared the Nobel
Prize with Bernardo Houssay for
research on the catalytic conversion of
glycogen. At the Nobel dinner, Carl Cori
referred to collaborating with his wife:
"Our efforts have been largely comple
mentary, and one without the other
would not have gone so far as in

Luis F. LeLoir, Nobelist in
Chemistry in 1970, received the
prize for his discovery of sugar
nucleotides and their role in the
biosynthesis of carbohydrates. He
was a research assistant to the
Coris in 1943.

Arthur Kornberg (left) and Severo Ochoa, Nobel Prize winners in 1959,
discovered the mechanisms in the biosynthesis of ribonucleic acid and
deoxyribonucleic acid. Ochoa worked in the Coris' lab in 1941 and 1942;
Kornberg was a visiting investigator there in 1947.

collaboration." In describing their
laboratory work, a biographer noted,
"The manual labor and tedium of these
experiments were considerable. Collabo
raWrs were few in number by prese-nt
day standards, and automation was
nonexistent. "
Despite these difficulties, the Coris
always attracted young scientists to their
laboratory. In his 1971 Nobel lecture,
Earl Sutherland recalled: "When I
returned to St. Louis after medical
service in World War II, I was unde
cided as to whether I should enter
medical practice or go into research.
Cori convinced me, not so much by
anything he said so much as by his
example, that research was the right
direction to take." In fact, Sutherland
had co-authored a 1941 article (his first)
with Carl Cori while still a medical
student. His retrospective view is telling,
for it reveals how the Cori-created
laboratory environment shaped his
future: "I believe that kind of stimulat
ing environment, with the necessary
critical mass of young and talented
investigators, with the opportunity for

Christian de Duve won the
Nobel Prize ill 1974 for discov
eries concerning the structure
and functional organization of
the cell. He worked in the Cori
lab as a Rockefeller Foundation
Fellow and collaborated there
with Earl Sutherland.

was no research factory with people
following detailed protocol laid out by
others; it was a collection of extremely
talented individuals doing their own
work with their own hands. In that
environment, sinking was unthinkable. I
felt privileged to be present...."
What was the magic of the Coris'
lab? Sutherland identified two crucial
ingredients: a critical mass of talented
young scientists and the free exchange
of ideas. By today's standards, their
laboratory was small and modest, but the
level of intellectual activity and scien
tific discourse was extraordinary. Severo
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the free exchange of ideas, is an impor
tant ingredient in the making of scien
tific progress." This acknowledgment
meant enough for Cori to quote it in a
posthumous National Academy biogra
phy of his fOimer student.
Washington University Chancellor
William H. Danforth, M.D., also was
among those who worked in the Cori lab
and had the course of his life affected by
the association. At Carl Cori's memorial
service, on November 16, 1984,
Danforth said, "The Cori department

Ochoa, a 1959 Nobel laureate who
worked there in the early 1940s, noted
that "everyone was invited to comment
on papers before publication."
As Krebs recently recalled: "The
training I received in the Coris' labora
tory as a postdoctoral fellow provided
me with the actual tools that I needed to
get started.... By 'tools' I'm referring
not just to techniques but also to a host
of other things that go into research ~
inquisitiveness, thoroughness, breadth of
interests and hard work. Gerty Cori's

Earl Sutherland received the
Nobel Prize in 1971 for his
discovery concerning the meclla
nisms of hormones. He was a
student laboratory assistant from
1940 to 1942 and later an instruc
tor, an assistant professor and an
associate professor.

highest praise for someone was to refer
to him or her as a 'good worker.' ... The
actual scientific contributions of the
Coris served as the basis for what was to
become my major life's work .... My own
research was built on the foundation that
they laid."
After the Coris' 1947 move to the
Department of Biochemistry, their
research group grew considerably. Even
so, the atmosphere of mutual collabora
tion and collegial support remained.
Enriched by the experience, former
laboratory members would make
independent contributions to knowledge
in uoiversities across the country and
around the world.
Lo 1953, Gerty Cori wrote: "For a
research worker, the un forgotten
moments of h.is l.ife are those rare ones
which come after years of plodding
work, when the veiJ over nature's secret
seems suddenly to lift and what was
dark and chaotic appears in a clear and
beautifui l ight and pattern...." Thanks to
formative years in the Coris' research
enterprise, many other scientists have
experienced those moments. •
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Personal Outlook
The tritieal Link: Health altd Human Rigltts
by Jonathan Mann, M.D.
he worldwide AIDS
epidemic was the first
epidemic to arise dur
ing the modem era of human
rights. As a result, it is not
surprising that the dialogue
between public health and
human rights perspectives

T

Jonathan Mann, M.D.,
M.P.H.
during the HIV pandemic
has been complex and some
times difficult. Yet, through
this experience, a clearer un
derstanding of the inextri
cable linkage between health
and human rights has led to
the creation of a new field of
academic research, teaching
and practice - and to the
world's first center focusing
on this critical relationship at
the Harvard School of Public
Health.
The modern era of human
rights started after World
War II, with the approval by
the United Nations General
Assembly of the Universal
Declaration of Human

24

Rights. Briefly yet power
fully, the universal declara
tion responded to the
atrocities of Nazi Germany
with a clear statement that
all people are born with
rights that adhere to them
simply because they are hu
man and that governments
cannot take away. Since the
adoption of the declaration
in 1948, an important foun
dation of documents and in
stitutions and a network of
nongovernmental organiza
tions have been created to
explore the meaning and to
work to ensure respect for
the entire range of human
rights.
I think my own experi
ence is somewhat typical. I
never encountered the idea
of human rights in any for
mal sense during either my
medical or public health
training. Indeed, most physi
cians are unfamiliar with the
basic concepts, the docu
ments, the institutions and
the practices of modern hu
man rights . Yet, as I hope to
demonstrate, there are practi
cal and powerful reasons beyond simply being an edu
cated person - for physi
cians and other health
workers to become literate in
human rights.
Back for a moment to the
AIDS pandemic. During the
early years , as policies and
guidelines for preventing
HIV transmission were de-

vel oped and as tools such as
the HIV serologic test be
came available, direct con
flicts arose between public
health experts and human
rights advocates . Health offi
cials often acted as if health
objectives (preventing HIV
spread) and human rights
objectives (protecting the
rights and dignity of the in
dividual) were at logger
heads.
For example, some public
health officials promoted
mandatory screening for
HIV infection, while rights
advocates resisted practices
which threatened individual
freedoms. In the end, the hu
man rights viewpoint gener
ally prevailed, as health
officials came to the prag
matic conclusion that if the
people they wanted to reach
with education about HIV
were punished or threatened,
they would go underground
and not participate in pre
vention programs.
However, as the pan
demic intensi fied and spread
to countries worldwide, an
other dimension in the rela
tionship between health and
human rights emerged. Let
me explain using an ex
ample: In parts of Eastern
Africa today, monogamous,
married women are becom
ing infected with HIV. Their
risk factor is their powerless
ness to influence their
husband's sexual behavior.

The inferior role and low
status accorded to women
results in their inability to
say "no" to unwanted or un
protected sexual intercourse.
Thus, despite their knowl
edge about HIV / AIDS and
even despite the availability
of condoms , these women
face a choice between refus
ing sex, with the likelihood
of physical violence and di
vorce (leading basically to
civil and economic death),
and risking HIV infection.
In response to this situa
tion , women's organizations
are working to reform the
laws and customs governing
property distribution after
divorce. If civil and eco
nomic survival following
divorce can be assured, HIV
prevention will be helped
much more than it would be
by the distribution of addi
tional condoms or brochures
on AIDS. The general mes
sage from this specific ex
ample is clear: The fact of
being marginalized, stigma
tized or discriminated
against in society is at the
basis of an increased risk of
being exposed to HIV .
Once it is clear that dis
crimination increases \rulner
ability to HIV - through
having less access to infor
mation, services and support,
or by being less able to put
into practice the practical
implications of prevention
messages - the way for

ward for public health
against ArDS is clear. Not
only must existing programs
of education, health and
social services and social
support continue to be devel
oped and strengthened, but
we must remove and prevent
societal discrimination.
Thus, for example, promot
ing an equal role for women
becomes a critical strategy
for improving public health.
Looking beyond AIDS,
we can see at least three di
mensions in a health and hu
man rights relationship.
First, it is clear that abuses
of human rights - - whether
torture, or inhumane treat
ment during imprisonment,
or rape or denial of the right
to information
have im
portant health impacts. Yet
even these impacts are often
not well documented, or un
derstood.
For example, we now
know that prolonged impris
onment under inhumane con
ditions creates lifelong
threats to physical and men
tal health which require pre
venti ve services and care.
Still another example in
volves rape during warfare
or undeclared conflict. The
tragedy in Bosnia is particu
larly abhorrent because rape
has apparently been a sys
tematic and deliberate
policy. But how much is
known about the frequency
and incidence and conse
quences of rape during other
conflict situations, including
insurgencies and various un
declared conflicts? It is im
portant to document the
health consequences of hu
man rights abuses, system
atically and carefully, in
order to understand better
how to prevent their occur
rence and to ameliorate their
impact.

A second dimension of
the health-human rights rela
tionship involves the ways in
which health policies, pro
grams and practices can have
adverse effects on human
rights. For example, the
practices of quarantine and
isolation are part of the lexi
con of public health re
sponses to epidemic disease.
But these practices violate
individual rights. How effec
tive is isolation, and what are
its direct and hidden costs?
Is the evidence strong
enough to justi fy burdening
human rights? Before jump-

of human rights as legitimate
concerns require that health
workers become human
rights Iiterate.
The third dimension re
turns to the recognition that
social justice - or to put the
matter negatively, societal
discrimination - is critical
to efforts to promote hea lth.
While the general relation
ship between health and
rights - such as the right to
information, to education, to
recognition as a person be
fore the law, to freedom of
movement, to the right to
marry and found a fami Iy, to

In the n1HtIerll wnrl(l. tlu~ existence
and acknowledgnlcnt of (uIluan
rights as legititnate concerns
require that health workers
/

he(,(Hnp

hLllnan-rights li tera te.

ing to conclusions, we must
reca 1I tha t medica I leaders
actively participated in de
veloping Nazi ideology and
practices, under the guise of
the pseudo-science of racial
hygiene. By taking the con
cept that the "diseased" part
must be sacri ficed for the
health of the rest, Nazi doc
tors promoted the practices
(starting with euthanasia and
killing of the handicapped)
which led directly to the
death camps. What was
missing so desperately from
Nazi Germany was respect
for individual human rights.
In the modern world, the ex
istence and acknowledgment

freedom of opinion and ex
pression - is clear, the
mechanisms and interactions
need to be better understood.
Finally, what is the mean
ing of the right to health?
The right to health goes be
yond access to quality health
care, although this would be
a great achievement for
American society. The pre
amble to the constitution of
the World Health Organiza
tion states that people have a
right to the highest attainable
standard of health, and that
this is fundamental to world
peace and security. At a
larger level, the ArDS
pandemic demonstrates the

extent of global health-inter
dependence: An obscure
event somewhere rapidly
became a health crisis here
and around the world.
Thanks to the generosity
of the Swiss-based Associa
tion Francois-Xavier
Bagnoud, the first academic
center to focus exclusively
on health and human rights
was established in January
1993 at Harvard. The
Francois-Xavier Bagnoud
Center for Health and Hu
man Rights (named after the
young Swiss helicopter pilot
who died on a rescue mis
sion in West Africa in 1986)
will link the academic
strengths of research and
teaching to field work that
addresses real public health
problems.
For me, the discovery of
the inextricable relationships
between health and human
rights has been a gradual
process, based on my work
to fight epidemic disease and
to promote health. I believe
that the pragmatic idealism
of physicians will add tre
mendous strength to a grow
ing global capacity to
prevent disease and promote
health, as we seek to put
health and human rights at
the center of our human
commitment. •

Ed Nole: Jonathan Mann, M.D.

is a 1974 graduate of the School of
Medicine. He is the former chief of
the World Health Organization'S
AIDS programs, director of
Harvard's Global AIDS Policy
Coalition and chaired the 8th inter
natIonal Conference on AiDS in
Amsterdam.
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he office of Leopo ld
a nd bee n named a fe llow in
Hofstatter, M.D., is
the A meri ca n Associa tion
simp le and tidy, al
for the Adv ance ment of Sci
most modest. When he's no t
ence in honor of his contri
buti ons.
the re, tw o objects dominate
the small space: a Webster's
For a lmost a century no w,
unabridged dictionary on a
his pre ference has been to
desk sta nd and a large paint
stay busy, keeping ou t oftbe
ing on the wall op
posite .
The dictionary is
symboli c of
Ho fstatter' s close
acqu a intance with
language and th e
breadth of his inter
ests. Th e painting,
done by his first
w ife, Lilli , is more
intimately s ignifi 
can t. The po rtra it's
creator as ide, it is
the subject - a
young man untm s
takab ly with a men
ta I illness, his eyes
close d and a pain
full y blank expres
s ion on his pal e face
- that embodi es
Hofstatter 's dedica
LeopoLd Hofstatter, M.D.
ti o n to serv ice to
others.
At 91 and s incerely mod
spo tlight. "J have a lways
est, he clea rly is uncom fort
liv ed in the serv ice of my
fell ow man," Hofstatter says .
able being the subject of an
intervi ew. " [ am just an ordi
The habit began in hi s birth
nary huma n being, nothing
place of Vienna , Austria,
ex tra ," he says, thou g h he
when , as the oldest o f four
has in fluenc ed more th a n a
c hildren, he often saw that
hal f-c entury of psyc hiatry,
his sisters were ca red fo r. As
worked to improve the lot of
a boy , he collected po stca rd s
depicting religious paintin gs
psychiatric patients, pio
neered more restri cted
- no t fo r persona l g rati fica
psyc hosurgica I tecbniq ues
tion or gai n but to make tbe
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Bibl e more appealing and
acces sible to others.
During the hard days of
World W ar I, Hofstatte r pre 
served food fo r his family
and app lied a method by
which their meal s co uld be
cooked , despite a s horta ge of

gas for the stove. Young
Leopold bu ilt a s upe r-insu 
.I ated ch es t that kep t fo od
cook in g for fo ur hou rs while
he was at wal tz and ta ngo
class with hi s s isters. " W e'd
com e ho me to have rice
boiled in milk with choco late
powder o n top ," he say s, de
li g hted at the memory o f
hav ing don e well in adver
s ity.

" [ always have a project
to wo rk on ," Hofstatter says.
He m ade a doorbell and th e
crude battery to powe r it for
the apartment building his
fa mily occupied in Vienna.
The building was construct
ed before th e s iege of Vienna
by Turk is h troops in
1683 and had no
provision fo r electri
ca l w ires. But
Hofstatter knew his
family would app re
ciate the conve
nience of a doorbe ll ,
so he c reated on e.
His proj ec ts were
done on the s ide
while s tudyin g
Lat in , French and
Engli sh in sc hoo l,
Itali a n, Spanish,
Russian and
Croa tian on hi s own .
A se nse of inno
va ti o n inspired by
common sense a lso
has in fused
Hofstatter's profe s
sionallife a nd its
projects. He was
steered toward medi
cin e by its purpose o f serv 
ing people directl y. A s trong
sen se of anti-militarism born
of the horror of World W ar 1
and his un c le ' s du ty as com
mander of a flame-thrower
un it bolstered that choice.
Out of respec t for his pa
tients as human beings,
Hofsta tter years la te r was
responsible for li m iting th e
extent of su rgery to the fron

tal lobes when providing re
lief from otherwise chronic
and treatment-resistant men
tal illness. His approach,
based on the principle,
"First, do no harm," became
a milestone in the history of
psyc hosurgery.
That may have been his
greatest single contribution,
but smaller examples reflect
the same ethic. When he be
came assistant superinten
dent at St. Louis State
Hospital in the '40s, he
added a napkin, a glass of
water, a fork and a knife to
the place settings at patient's
meals where previously only
a spoon had been provided.
During World War II, he
made raisins a part of
most menus, improv
ing the patients' diets
with iron. And he in
sisted on smaller ward
sizes in the Missouri
Institute of Psychiatry
building to encourage
socializing among pa
tients and staff. At
every opportunity, he
improved psychiatric
patients' morale by increas
ing the level of respect
shown to them.
When Missouri's gover
nor came to review changes
he had made as superinten
dent at the State School and
Hospital, Hofstatter turned
away the politician's con
gratulations by telling the
governor, "You don't have
to be a doctor to understand
this. Common sense tells
you. A tool is an extension
of the arm; all learning is an
extension of common
sense."
During his medical train
ing at the University of
Vienna, Hofstatter was asked
to translate a chemistry pa
per on newly discovered iso
topes from English into
German in preparation for a
visit from a famous scientist.

When Albert Einstein ar
rived in class, Hofstatter
read the paper to the man he
came to regard as a hero, and
the two were photographed
together with Professor
Schlenk, head of the
university's chemistry de
partmen t.
After graduation,
Hofstatter intended to be
come a surgeon, but Nobel
Prize winner Konstantin von
Economo saw his transparent
model of the human brain
(made from urea, the first
plastic) and encouraged him
to direct his attention to neu
rology and psychiatry - a
single discipline in Europe at
the time.

therapy, which Hofstatter
calls "a fraud from the be
ginning," was for a while
accepted beyond anyone's
imagination. And hydro
therapy "has been given up,
although it is beneficial," he
says.
"Some of the condi tions
that used to be common are
almost unknown today," he
says. "For example, take
congenital syphilis. Now, we
treat syphilis early and effec
tively, so it no longer is
passed along. I saw many
tragic instances of general
paresis of the insane, another
rare condition today. We
stopped its progression, but
we couldn't bring life back

A.t every opportllnity~ hp in1IH'O\pd
psyehiatric patients,) 1110rale by increasing
the level of reRpeet shown to then1.

In early 1938, Hitler's
armies marched into Vienna.
The date was March II,
Hofstatter's birthday. He and
Lilli soon left and shortly
therea fter settled in St.
Louis, where Hofstatter had
obtained a research fellow
ship in neurosurgery with
Ernest Sachs at the medical
school. He taught applied
neuroanatomy and, later,
psychiatry to med ica I stu
dents.
During his long involve
ment in psychiatry,
Hofstatter has witnessed
many changes. His early spe
cia Ity of psychosurgery is
little practiced since the ad
vent of psychotropic drugs.
The paternalistic attitude that
early psychiatrists some
times adopted toward their
patients is gone. Insulin

to the celts killed by invad
ing spirochetes," is his sad
observation.
When he met von
Economo, the scientist had
contracted with the Soviet
government to preserve for
future study the brains of
elite thinkers after their
deaths. The plan was to ex
amine the brain tissue micro
scopically to discover the
source of their genius.
"Those people were com
pletely unaware of the
chemical and electrical pro
cesses that occur in cerebral
activity, and there was very
little to be learned from his
tological studies," Hofstatter
says.
Through it all, Hofstatter
has kept pace with change.
Today, he follows the devel
opment and application of

brain visualization tech
niques like positron emission
tomography (PET) and mag
netic resonance imaging
(MRI). He is paliicularly
interested in applying them
to the study of the effects of
early childhood experiences
on myelination and on social
behavior. And he partici
pates in a project for the St.
Louis Science Center that
will include history's many
great thinkers, writers, com
posers and others who ha ve
suffered from mental ill
nesses.
He spends part of his time
caring for and playing the
piano for his wife, Theresa,
hersel f a pianist. On most
days, Hofstatter goes to
his small office to work
on his projects. He re
peatedly ponders one
question: "I've always
wondered and been sur
prised at the trust, con
fidence and respect
shown me by my fam
ily, colleagues and su
periors. I was fortunate
to have the best teach
ers and examples to learn
from and to be inspired by. I
happened to stumble on a
few things. I keep myself
going. [just can't help being
interested," he says, shifting
the dictionary to sit squarely
on his desk.
Hofstatter characteristi
cally has avoided honors and
awards, declining to join
even most professional soci
eties. Other rewards have
been more important. To il
lustrate, he tells the story of
how, when Lilli's painting of
the mental patient had been
hanging on his wall for some
time, he encountered the
man in the portrait. Working
as an elevator operator, the
man had been treated suc
cessfully. "That's what gives
me satisfaction," he says . •
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The Coleman Foundation Symposium, presented Friday,
February 5, treated the subject "Molecular Oncology: Novel
Approaches to Understanding and Treatment." Among the
dignitaries on hand were (left to right): Michael W.
Hennessy, vice-president oIThe Coleman Foundation; John
E. Hughes, presidellt of The Coleman Foundation; Thomas
F. Deuel, M.D., symposium organizer and moderator of the
morning session; Jean D. Thorne, executive director of the
foundation, and William A. Peck, M.D., executive vice chan
cellor and dean of the medical school. The Coleman Foun
dation Symposium, presented annually, rotates among six
midwestern medical schools andfocuses on recent discover
ies in basic cancer research. Located in Chicago, the founda
tion has been a continuous supporter ofthe mel/ical school.

P 'ograul
D dicat d To
Paul IIoc ges
he Radiological So
ciety ofN011h
America (RSNA)
dedicated the printed pro
gram of its 78th Scientific
Assembly and Annual Meet
ing to Paul C. Hodges, M.D.,
Ph.D., the oldest living
graduate of the School of
Medicine. Hodges graduated
in 1918, and he celebrated
his 100th birthday on Janu
ary 6, 1993.
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During his career, Hodges
organized radiology depart
ments at the University of
Chicago and the University
of Florida, trained leaders in
the field and developed inno
vative technological ad
vancements, such as the
phototimer. He taught physi
ology and worked as a
Roentgenologist in China
and returned to the Orient
after his retirement.
The RSNA meeting, con
vened each year in Chicago, is
the single largest scientific
meeting held in the country . •

t its January 25
meeting, the Execu
tive Council of
WUMCAA voted to name
Distinguished Alumni Schol
arships in honor of Leonard
Berg, M.D. '49; Robert C.
Drews, M.D. '55; John
Kissane, M.D. '52, and J.
Neal Middelkamp, M.D. '48.
Sixteen such scholarships
had been established. The
scholarships are the school's
major merit-bascd scholar
ship program funded by pri
vate support. Funded
partially by annual gi fts from
alumni, former residents and
other donors, they recognize
beloved teachers. Each
named scholarship provides
a first-year recipient with
$10,000 toward tuition costs.
The medical school then
matches the grant up to the
full amount of tuition. The
scholarships continue for the
four years of medical educa
tion .
Leonard Berg, M .D. ,
joined the faculty in 1955 as
an instructor in clinical neu
rology and was named pro
fessor in 1972. Today , he is
director of the Alzheimer's
Disease Research Center.
Robert C. Drews, M.D.,
professor of ophthalmology,
has been on the clinical staff
since 1966. In 1979, he
served as the president of
WUMCAA.
John Kissane , M.D .,
joined the faculty in 1958
and is professor of pathology
in pediatrics. In 1970, he
was selected Teacher of the
Year by the graduating class.

A

J. Neal Middelkamp ,
M .D., professor of pediat
rics, has been on the faculty
since 1953 . He was honored
with an Alumni/ Faculty
A ward from WUMCAA in
1988.
Established in 1989 by
WUMCAA, the named
scholarships are not based on
financial need but on aca
demic merit and the excep
tional personal qualities
required for the successful
practice of medicine . •

S..ohaefer Trust
DOl1ale~

$1.35

Million

T

he School of Medi
cine has received a
$1.35 mi Ilion dona
tion to fund research in the
division of pulmonary and
critical care medicine. The
donation comes from the
trust of Martin W. Schaefer,
a Belleville IL native, who
died in 1991 from emphy
sema, a common respiratory
disease that destroys the
lungs by causing inflamma
tion of the connective tissue
framework. Schaefer hoped
a tmst would fUl1her re
search and aid in the devel
opment of new treatments.
"Emphysema and other
associated severe respiratory
disorders constitute a group
of diseases affecting an in
creasing segment of our
adult and aging population,"

says David M. Kipnis,
M .D., distinguished univer
sity professor in the Depart
ment of Internal Medicine.
"The ability to expand our
research activities in under
standing the pathological
events leading to these disor
ders and to devise mecha
nism-based therapeutic
strategies to treat them repre
sents an extraordinary oppor
tunity for our scientists
engaged in this area of clini
cal investigation."
Schaefer was born July
16, 1923, and attended pub
lic school in Belleville. He
was drafted into the U.S.
Army in 1942 and dis
charged in 1946, after which
he joined the Army Reserve .
He was called back into ser
vice during the Korean con
flict and opted for a military
career at the end of that war.
He retired as a colonel in

1970.
The respiJatory and criti
cal care division is known
for its research in asthma
and pulmonary obstructive
disease and has the largest
lung transplant program in
the world. The division di
rector is Michael J.
Holtzman, M.D . •

AOA Holds
Banquet

L

eonard Slatkin, music
director and conduc
tor of the St. Louis
Symphony Orchestra, was
the featured speaker at the
annual initiation banquet of
the Washington University

Chapter of Alpha Omega
Alpha, held at the University
Club on Wednesday, January

27.
Nearly 200 members and
guests of the chapter at
tended the induction of 20
members into the medical
honor society, the president
of which is Kenneth M .
Ludmerer, M.D.
Fourth-year medical stu
dents inducted were: Daniel
E. Buerger, Douglas T. Can
non, Lynne M. Champagne,
Paul 1. Cummings, Lora K.
Eichner, Jodie A. Escobedo,
Robert A. Fontes, Jr.,
Michele L. Francoeur,
Patrick R. Gannon, Kirk P.
Gasper, Cecilia M.
Redmond, Theodora S. Ross,
Dan G. Sewell, Vishwas R.
Talwalkar and Robert J.
Teaford. Also inducted were
three graduate trainees: John
E. Frattini, James R. Howe
and Charles M . Kilo .
Each year, the chapter
elects one new faculty mem
ber and one new alumnus.
This year, the new faculty
member is Patricia L. Cole,
M.D., assistant professor of
medicine and associate dean
for student affairs. The new
alumnus is Alan J.
Tiefenbrunn, M.D., associate
professor of medicine.
AOA councilor John D.
Davidson, M.D., coordinated
the banquet arrangements
that included entertainment
by a string quartet composed
of school of medicine stu
dents Jacqueline Hoffman
and Soham Roy from the
Class of 1995 and Nicole
Willeumier and Adam Eaton
from the Class of 1996.

TI1e AOA chapter will host
visiting professor Al Tarlov,
M.D., on April 22 and 23.
Tarlov, of the division of
health improvement of the
Health Institute of the New
England Medical Center, Bos
ton, is expected to speak on
health care reform . •

Danforth has called her one
of hcr generation's great
benefactors: "She showed us
how to enjoy life's gifts
while sharing them with oth
ers. I am thankful that she
chose Washington Univer
sity as a partner in doing
good for the generations
ahead. " •

Bequest Will

Fund Arthritis
R

CLAS,~

'20s and '30

W

ashington Univer
sity has received
a $2 million be
quest from the estate of
Audrey L. Levin, according
to an announcement by
Chancellor William H .
Danforth, M .D.
The bequest will establish
an endowment in the Depart
ment of Medicine to fund
one, possibly two, chairs to
further research into arthritis.
Mrs . Levin and her husband,
the late Sam 1. Levin, were
internationally recognized
philanthropists and art col
lectors. They contributed
many works of art to muse
ums in Israel and the United
States, including paintings
and sculptures to St. Louis
University, Washington Uni
versity and the St. Louis Art
Museum .
Mrs. Levin was the
founder of Audrey Levin
Realtors, a successful real
estate firm specializing in
commercial property. She
was a member of Washing
ton University's William
Greenleaf Eliot Society.

Gervais D. Smith, M.D. '22

Gervais D. Smith, M.D.
'22, worked as a general
practitioner in Bolivar MO
for 66 years. Now 96, he
lives in a healthcare faci lity
in Springfield where his wife
of 52 years spends the day
with him. She writes that he
"has always been very proud
to be a graduate of Washing
ton University."
Joseph B. Kendis, M.D.
'33, writes that he retired
about five years ago and is
" living the easy life now,"
after many years working in
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alcoholism and drug abuse
both in private practice and
at the Hyland Center at St.
Anthony's Hospital in St.
Louis.
Kenneth M. Amlin,
M.D. '35, has moved to San
Mateo CA after living in
Arnold CA, at an altitude of
4,000 feet in the Sierra Ne
vada, for 21 years. He writes
that he was "tired of being
snowbound after heavy
storms." He would like to
hear from his classmates at
75 W. 5th Ave., San Mateo
CA 94402.
E. Norris Robertson,
M.D. '37, sends word that he
and his wife, Mary, have
been married for 56 years,
residing in Oklahoma since
the end of World War II. The
couple has one son and one
daughter, two grandsons and
two granddaughters.
Robertson is engaged in the
private practice of ophthal
mology and holds the rank of
clinical professor of ophthal
mology at the University of
Oklahoma Health Center.

40 and '.50s
William S. Curtis, M.D.
'40, received the University
of Colorado medal at winter
commencement exercises at
the University of Colorado
Boulder. Curtis is a longtime
member of the student health
center medical staff.
Roland R. Cross, Jr.,
M.D. '40, in November re
ceived the Stritch Medal
from Loyola University for
his contributions that include
23 years on the admissions
committee.
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Harry E. Lichtwardt,
M.D. '43 (December), re
tired from active practice in
urology nine years ago when
he was working as chairman
of the Department of Urol
ogy at William Beaumont
Hospital in Royal Oak MI,
one of the 10 largest admit
ting hospitals in the nation.
He serves on the Executive
Committee of the American
Urological Association and
divides his time between Or
chard Lake MI, and Naples
FL. He and his wife,
Genevieve, also visit their
three grandchi Idren and two
sons in California and Mon
tana.
James O. Davis, M.D.
'45, Ph. D., received the Dis
tinguished Alumni Award
from the College of Arts and
Sciences at the University of
Missouri on February 19.
Davis, who retired in 1982,
worked for many years at the
National Heart Institute and
did research that led to the
development of enzyme in
hibitors used in the treatment
of heart disease. He served
as chainnan of the Depart
ment of Physiology at the
University of Missouri be
ginning in 1966, and a pro
fessorship in cardiovascular
research is established in his
name there.
Robert H. Tanner, M.D.
'47, has received the special
service award from Memo
rial Community Hospital in
Jefferson City MO. The
award is presented for out
standing service to the hospi
tal, the community and the
surrounding area. A family
practitioner, Tanner is a

member of the medical staff
at Memorial Community
Hospital, served on the utili
zation review committee and
the board of trustees. He is a
life member of the hospital's
board of governors and has
served as president, vice
president and secretary/trea
surer of the medical staffs at
Memorial and St. Marys
Health Center.
Lowell A. Gess, M.D.
'51, reports that he "emerged
unscathed from a military
coup in Sierra Leone, West
Africa," and planned to do
more eye surgery at the
Kissy UMC Eye Hospital in
Freetown during January,
February and March of this
year.
Marvin E. Levin, M.D.
'51, and Lawrence \V.
O'Neal, M.D. '46, have just
published the fifth edition of
the text The Diabetic Foot.
The third editor is John H.
Bowker, M.D., ofthe Uni
versity of Miami School of
Medicine. Recently, Levin
was a visiting professor in
Cairo as a guest of the Egyp
tian Diabetes Care Associa
tion.
Philip S. Crossen, M.D.
'54, has retired from active
practice but continues as
medical director at Planned
Parenthood of Lexington
KY. He writes, "Doesn't pay
too well, but it is very satis
fying, and they don't fire me
when we are away for ex
tended time to Michigan in
summer and Florida in win
ter. "

'60s lind -70s
Mary Ann Reynolds,
M.D. '62, retired from pri
vate practice on December
31 , 1992, Harry Reynolds,
M.D. '60, continues to work
part-time as a locum tenens
general surgeon. They write
that they hope to travel both
in the U.S. and abroad. The
couple resides in Turlock
CA.
Jim Murdock, M.D. '63,
and his wife (Marilyn) and
children live in Eugene OR
on a small mountain with
Arabian horses, German
shepherd dogs and Siamese
cats. Jim is active in the sur
gical community at Sacred
Heart General Hospital and
keeps up his music, having
performed with the Eugene
Symphony. The couple has
three daughters: Lynn re
cently graduated from
Carleton, Elizabeth is a j un
ior at Yale, and Katie is in
her first year at Sewanee.
David L. Dunner, M.D.
'65, is president of the Soci
ety of Biological Psychiatry
for 1992-'93. Dunner is pro
fessor and vice chairman for
clinical services in the De
partment of Psychiatry and
Behavioral Sciences at the
University of Washington.
He edited the recent publ ica
tion, Current Psychiatric
Therapy (W.B. Saunders,
Co., 1993). His wife; Peggy
Zolbert Dunner, OT '64,
operates an antique jewelry
business near Seattle.
David C. Bisno, M.D.
'66, sold his Atlanta ophthal
mology practice in the spring

of 1992 and has since been
enjoying studying the history
of science at Dartmouth Col
lege and Harvard University.
He reports that his daughter
is an "aspiring, although un
employed," actress, and his
son is a third-year rabbinical
student.
Steven B. Raffin, M.D.
'68, wrote a chapter for the
16th edition of the Merck
Manual.
Charles L. Rich, M.D.
'69, has assumed the posi
tion of chairperson of the
Department of Psychiatry at
the Univcrsity of South Ala
bama. His previous position
was with the State Univer
sity of New York at Stony
Brook. He also is editor-in
chief of the Annals of Clini
cal Psychiatf)' and was listed
recently in the book, The
Best Doctors in America.

'80s
Wilfred G. Ellis, M.D.
'82, has been awarded the
AIDS Service A ward from
the State of Ohio for 1992.
Ellis has been an advocate
for his patients and commit
ted to the local AIDS Task
Force, as well as being an
early supporter of the Ryan
White initiative. He is chair
man of infectious diseases at
the St. Rita ' s Medical Center
in Lima OH.

the Department of Otolaryn
gology at Jewish Hospital in
Cincinnati. He also was
elected recently to the Coun
cil of the Cincinnati Acad
emy of Medicine.
John S. Spratt, M.D.,
FHS in surgery, is a Naval
Reserve captain and a clini
cal professor of surgery at
the Uniformed Services Uni
versity for the Health Sci
ences in Bethesda MD. He
recently attended the annual
meeting and luncheon of tile
editorial advisory board and
reviewers for the joumal
Military Medicine.
Fremont P. Wirth, M.D.,
FRS in neurosurgery, has
been appointed a director of
the American Board ofNeu
rological Surgcons. The 14
member board, organized in
1940, is the certifying board
for neurosurgeons in the
United States. Wirth prac
tices in Savannah GA, where
he currently serves as secre
tary of the Georgia Medical
Society.
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Robert Maltz, M.D.,
FRS in otolaryngology, has
been appointed director of

R

Calvin R. Robinson, HA '76
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Larry L. Mathis, RA
'72, is president and chief
executive officer of The
Methodist Hospital System
and its 10 member corpora
tions, including The Method
ist Hospital, a 1,527-bed
tertiary care, education and
research facility located in
the Texas Medical Center in
Houston. He is chairman
elect of the board of trustees
of the American Hospital
Association. Healtlzweek
magazine named him one of
25 top multi, alLiance and
buying group executives in
the nation, and Business
Week named him one of the
five best managers in non
profit health services in the
U.S.

Larry L. Mathis, HA '72

Calvin R. Robinson, HA
'76, has been appointed to
the position of vice president
of operations for Meridia
Huron Hospital in Cleve
land. He resides in Cleveland
Heights.
Jim Humphrey, RA '87,
and his wife, Loraine, are
expecting their first child in
May. Jim is director of man

aged care at Corona Medical
Center in Corona CA.
Rose J. (Catron) Flynn,
NU '51, retired at the end of
January fr0111 the Baptist
Memorial Hospital System
in San Antonio TX, after
working there for 21 years.
She says her plans are in
definite, but that she and her
husband have lots to keep
them busy, including enjoy
ing their grandchildren.
Martha Sue Sublette
Birk, OT '33 , has lived and
worked in Decatur lL since
she married Carl P. Birk,
M.D. '34, who practiced
medicine there for 51 years .
The couple raised three chil
dren and repOits that many
members of their extended
family are Washington Uni
versity alumni .
Anne Rothstein Ander
son, OT '77, her husband ,
Jim, and her son, Paul, live
in the shadow of Yosemite ' s
high peaks in Sonora CA.
Anne owns and operates a
small therapy practice spe
cializing in geriatric rehabili
tation.
Mrs. George Basinger,
PT '53, has completed 15
years as the director of
physical therapy at the East
Texas Medical Center 
Pittsburg. She continues to
serve the East Texas Re
gional Healthcare System by
extending its physical
therapy service to many
other northeast Texas medi
cal facilities.
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William J. Harrington,
M.D., former director of the
division of hematology here
and an internationally re
nowned blood specialist who
made major discoverics
about the mechanisms of
blood disorders from experi
ments he performed on him
self, died at his home in
Miami in October. He was
68 years old.
Harrington apparently
died while repairing a gen
erator outside his home that
had been without electricity
and running water since Hur
ricane Andrew hit the area
the week before.
M.K. King, M.D.,
Danforth Professor of Pre
ventive Medicine and former
dean of the medical school,
says Harrington "was Carl
Moore's greatest pupil."
Both men performed experi
ments on themselves in the
interest of advancing medi
cal knowledge . In 1950,
Harrington discovered that a
substance in the blood of
individuals with idiopathic
thrombocytopenia purpura
(ITP) destroyed their plate
lets. He made the discovery
by injecting a pint of an lTP
patient's blood into himself.
Almost immediately, his
own platelet count dropped .
He was admitted to Barnes
Hospital where, within a
week, his platelet count re
turned to normal, showing
that the factor that caused
ITP was in the blood.
At age 28, he became the
youngest member ever
elected to the American So
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ciety of CI inical Investiga
tion. Later, he moved to the
University of Miami, where
he founded the Center for
Blood Diseases, became the
chairman of the Department
of Medicine and founded the
Ph.D.IM.D. program. For 25
years, he worked to improve
medical education in Latin
America, and he made house
calls for as long as he prac
ticcd. Harrington earned one
of 70 Mastership awards
ever granted among the
60,000 members of the
American College of Physi
clans.
He is survived by his
wife, Mary, a daughter, three
sons and four grandchildren.
Robert A. Huckstep,
M.D. '48, died on November
28, 1992, at his home in
Farmington MO. He was 71
years old. A community
leader in Farmington,
Huckstep had been commit
ted to education and had
served on the local board of
education and the board of
trustees of Mineral Area
ColJege for 15 years. He had
been instrumental in the
building of Farmington
Community Hospital.
Though he had ofticially re
tired, he continued to work
part-time at Medical Arts
Clinic in Farmington.
Among his survivors are
his wife, Mary, two sons,
one daughter, one brother
and three grandchildren .
G. Leland Melson, M.D.
'65, professor of radiology,
died of cancer on November
10 at his home in Glendale
MO. He was 53.

Melson was a member of
the medical school faculty
for 20 years. He was highly
respected for his work as a
teacher and clinician, as well
as for his research on ab
dominal ultrasound imaging.
Melson received his
medical degree from Wash
ington University in 1965
and joined the faculty in
1972 as an instructor at the
School of Medicine's
Mallinckrodt Institute of Ra
diology. He became chief of
the clinical ultrasound divi
sion in 1977 and a full pro
fessor in 1983.
He received several hon
ors during his career, includ
ing being named a member
of the medical honorary so
ciety Alpha Omega Alpha
and a fellow of the American
College of Radiology. In
1989, he was recognized by
the St. Louis Metro Area
Sonographers for his contri
butions to the field of ultra
sound.
He published more than
50 scientific journal and
textbook articles and was an
active member of several
professional societies. He
served on the Missouri Ra
diological Society board of
directors, as vice president
of Alpha Omega Alpha's
local chapter at Washington
University and as a past
president of the Greater St.
Louis Society of Radiolo
gists. He also served on a
consensus-development
panel for the National Insti
tutes of Health.
A memorial service was
held November 13 at Salem
United Methodist Church in
Ladue. Among Melson's SUf

vivors are his wife, Brenda,
one daughter, two sons, his
mother, and a sister.
Jack R. Rhodes, M.D.
'45, died November 2 of
natural causes in Sheridan
WY, while he was attending
a building dedication at the
Sheridan Veterans Affairs
Medical Center. He was 71.
Rhodes began his general
surgery practice in Sheridan
in 1953 and served 30 years
on the staff of Memorial
Hospital there, including
holding the post of chief of
staff. Rhodes closed his
practice in 1983, joining the
staff at Sheridan V A Medi
cal Center. He retired earlier
in 1992.
Rhodes was active in Boy
Scouts, his church and fra
temal and professional orga
nizations. He was an avid
fisherman and traveler and
had just retumed from a trip
to England, Scotland and
Ireland. H is sudden death
came as a shock. Survivors
include his wife, Mary Eliza
beth, two daughters, five
sons, a sister and 13 grand
children .
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embNS of the
medical school
community with
news for their colleagues are
invited to send a note to
Ruth Bebermeyer, Medical
Alumni and Development
Office, Box 8049, 660 S.
Euclid, St. Louis MO 631 10.
Please include mention of
the variety and date of your
affiliation . •

All awards IUllcheoll was held in the King Center on December 8, 1992, to recognize out

standing achievements by students in the 1991-'92 academic year. Nancy E . MacDonald
received the CIBA-Geigy Award for Community Service and was presented with the complete
CIBA Collection of Medical Illustrations prepared by Frank H. Netter, M.D . CIBA ' s Kevin
Clark made the presentation. Honored along with MacDonald were medical students Michele
L. Francoeur, Timothy J. McCulley, Lawrence S. KaskO\,vitz, Michael E. Ohl, William L.
Lyons, Jennifer L. Paterson, Scott M. Pinter, Corina Jo Norrbom, Catherine Bradley,
Stephanie B. Cox, Ryland E. Melford, Korwyn L. Williams, Marianne Ingels, Martha S.
Terry, Mathias J. Kill, Lynne M. Champagne, Mark A. Koler and Tamara L. Densmore.

School of Medicine
Campus Box 8065
660 S. Euclid Ave.
St. Louis, MO 63110-1093

The birth ofRaja at the St. Louis Zoo on Sunday, December 27, was assisted by
staff in the endocrine laboratory of the Department of Obstetrits and Gynecol
ogy. Several elephant births in recent years have been complicated because zoo
staff could not know exactly when the calf was due. But Janet Willand, Alice
Hightower and Tonj Broeker of the lab tested the serum progesterone levels of
Pearl, the mother elephant, regularly. And on Saturday, the 26th, when Pearl's
progesterone level dropped from the 500-600 picograms per milliliter it had
averaged to I! 9 picograms, Hightower alerted zoo veterinarians that the birth
was imminent. Pearl was then monitored closely, and her early signs of labor
were detected. Raja has captured the city's affection.

